A drug derived from pyrovalerone which acts as a TRI, producing stimulating effects. Had been sold in a blend called "NRG-1" Little information exists about the safety profile of this drug.
Naphyrone molecular structure diagram from the DrugsPRO substance library.
Also known as: NRG-1, Energy-1, O-2482, Naphthylpyrovalerone
Classification
Chemical: Cathinone
Psychoactive: Stimulant
Tag: Habit-Forming
Tag: Research-Chemical
Effects
Stimulation
Physical Energy
Vasoconstriction Cold Extremities
Teeth Grinding
Jaw Tension
Insomnia
Euphoria
Talkativeness
Increased Focus
Anxiety
Panic
Compulsive Redosing
Light Sensitivity
Routes of Administration
Oral
Dosage
Common: 20-35 mg
Strong: 35-50 mg
Heavy: 60+ mg
Light: 10-20 mg
Threshold: 5 mg
Duration
Onset: 0.25-0.75 h
Peak: 1-4 h
Offset: 3-6 h
After Effects: 12-24 h
Total Duration: 6-12 h
Insufflated
Dosage
Heavy: 50+ mg
Light: 10-15 mg
Common: 15-30 mg
Strong: 30-50 mg
Threshold: 5 mg
Duration
Onset: 0.03-0.17 h
Peak: 0.5-3 h
Offset: 3-6 h
After Effects: 12-24 h
Total Duration: 6-10 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
This static page is intended as a readable non-JS and prerender-friendly library export.
Get the full DrugsPRO experience
Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.
Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu
Naphyrone - DrugsPRO Substanzleitfaden
Naphyrone: A drug derived from pyrovalerone which acts as a TRI, producing stimulating effects. Had been sold in a blend called "NRG-1" Little information exists about the safety profile of this drug.